To explore how ITGA6 might contribute to the radioresistance response of breast cancer cells, a protocol was established that allowed cell cycle progression to be monitored by flow cytometry following ITGA6 depletion using shRNA and IR exposure in MCF7, SKBR-3 and MDA-MB-231 cells. Here, ITGA6 is linked to breast cancer.